News

Pharmabiz52m
Drug control officers oppose Karnataka govt's plan to outsource third-parties to monitor regulatory compliance
Drug control officers oppose Karnataka govt's plan to outsource third-parties to monitor regulatory compliance: Peethaambaran Kunnathoor, Chennai Monday, August 4, 2025, 08:15 Hrs ...
Pharmabiz1h
Odisha DC dept and STF seize over Rs. 52 lakhs worth of codeine cough syrup in interstate bust
Peethaambaran Kunnathoor, Chennai Monday, August 4, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h
Indian CDMOs dominate in complex nutraceutical formulations with benchmark for innovation & reliability
Indian CDMOs dominate in complex nutraceutical formulations with benchmark for innovation & reliability: Nandita Vijayasimha, Bengaluru Monday, August 4, 2025, 08:00 Hrs [IST] Ind ...
Pharmabiz1h
DoP extends timeline for industry to file self-declaration under UCPMP for FY 2024-25
DoP extends timeline for industry to file self-declaration under UCPMP for FY 2024-25: Gireesh Babu, New Delhi Monday, August 4, 2025, 08:00 Hrs [IST] The Department of Pharmaceut ...
Pharmabiz1h
BDCDA demands action against Blupack and PillUp for unauthorized tampering of medicine strips
BDCDA demands action against Blupack and PillUp for unauthorized tampering of medicine strips: Nandita Vijayasimha, Bengaluru Monday, August 4, 2025, 08:00 Hrs [IST] The Bangalore ...
Pharmabiz1h
Imports of bulk drugs decline for the third consecutive month in June
The trend of decline in imports of bulk drugs and intermediates to the country continued for the third consecutive month of FY26, with a decline of 12.36% reported for the month of June, as compared ...
Pharmabiz1d
Pasithea completes enrollment and initial dosing of first Cohort from its phase 1/1b trial of PAS-004 in adult NF1 patients
Pasithea completes enrollment and initial dosing of first Cohort from its phase 1/1b trial of PAS-004 in adult NF1 patients: Miami Saturday, August 2, 2025, 18:00 Hrs [IST] Pasith ...
Pharmabiz1d
US FDA approves SetPoint Medical’s novel neuroimmune modulation device, SetPoint System for rheumatoid arthritis
US FDA approves SetPoint Medical’s novel neuroimmune modulation device, SetPoint System for rheumatoid arthritis: Valencia, California Saturday, August 2, 2025, 17:00 Hrs [IST] ...
Pharmabiz1d
BioDuro & Atombeat enter strategic partnership to launch an AI-powered platform for accelerated peptide drug discovery
BioDuro & Atombeat enter strategic partnership to launch an AI-powered platform for accelerated peptide drug discovery: Irvine, California Saturday, August 2, 2025, 16:00 Hrs [IST ...
Pharmabiz1d
Marengo Asia Hospitals inks strategic clinical partnership with Metis – The Medicity Hospital, Varanasi
Marengo Asia Hospitals inks strategic clinical partnership with Metis – The Medicity Hospital, Varanasi: Our Bureau, Mumbai Saturday, August 2, 2025, 15:40 Hrs [IST] Marengo Asi ...
Pharmabiz1d
US FDA grants fast track designation to Revalesio’s lead investigational therapy, RNS60 to treat acute ischemic stroke
US FDA grants fast track designation to Revalesio’s lead investigational therapy, RNS60 to treat acute ischemic stroke: Tacoma, Washington Saturday, August 2, 2025, 15:00 Hrs [I ...
Pharmabiz1d
Plus Therapeutics’ subsidiary, CNSide to launch CNSide cerebrospinal fluid assay platform in US
Plus Therapeutics’ subsidiary, CNSide to launch CNSide cerebrospinal fluid assay platform in US: Houston Saturday, August 2, 2025, 14:00 Hrs [IST] Plus Therapeutics, Inc., a cli ...